Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with resection of primary hepatic malignancy.

S Iwatsuki1, T E Starzl

  • 1Department of Surgery, University Health Center of Pittsburgh, University of Pittsburgh, Pennsylvania.

The Surgical Clinics of North America
|April 1, 1989
PubMed
Summary

Hepatic resection for primary liver cancer has an 8.5% mortality rate, but survival rates reach 31.9% at 5 years. Extensive resections like trisegmentectomy improve outcomes for large tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Appropriate management of high-flow priapism based on color Doppler ultrasonography findings in pediatric patients: four case reports and a review of the literature.

Journal of pediatric urology·2019
Same author

Chromosomal anomalies and sperm retrieval outcomes of patients with non-obstructive azoospermia: a case series.

Andrology·2017
Same author

Effect of obesity on sperm retrieval outcome and reproductive hormone levels in Japanese azoospermic men with and without Klinefelter syndrome.

Andrology·2016
Same author

Liver Resection for Primary Hepatic Neoplasms.

Acta chirurgica Austriaca·2013
Same author

WHICH LIVER-DESEASE PATIENTS NEED A TRANSPLANT?: Organ replacement has come into its own as a treatment for end-stage liver disease. A team of experts from two leading transplant centers reviews current indications, survival rates, and methods of evaluating candidates for operation.

Hospital record study : a joint study by CPHA and IMS America Ltd·2011
Same author

Hepatic Homograft Survival in Pediatric Orthotopic Liver Transplantation with Cyclosporine and Steroids.

Transplantation proceedings·2010

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Gastroenterology

Background:

  • Hepatic resection is a critical treatment for primary liver malignancies.
  • Understanding operative risks and survival outcomes is essential for patient management.

Purpose of the Study:

  • To summarize the experience with hepatic resection for primary hepatic malignancies.
  • To analyze operative mortality, survival rates, and factors influencing outcomes.
  • To evaluate the efficacy of extensive hepatectomies for large tumors.

Main Methods:

  • Retrospective review of 106 hepatic resections for primary liver cancer.
  • Analysis of 411 total hepatic resections for various indications.
  • Comparison of outcomes between primary malignancy and metastatic disease.

Related Experiment Videos

  • Assessment of survival rates at 1, 3, and 5 years post-resection.

    • Main Results:

    • Operative mortality for primary hepatic malignancy was 8.5%, higher than for hepatic metastases (0%).
    • Overall operative mortality for all hepatic resections was 3.2%.
    • 1-, 3-, and 5-year survival rates for primary hepatic malignancy were 68.5%, 45.1%, and 31.9%, respectively.
    • Fibrolamellar hepatocellular carcinoma showed significantly better survival than non-fibrolamellar types.
    • Eighteen patients survived >5 years, 14 after trisegmentectomy.
    • High-risk factors included cirrhosis, trauma, abscess, and large tumors.

    Conclusions:

    • Hepatic resection for primary liver cancer carries significant operative risk but offers potential for long-term survival.
    • Extensive partial hepatectomies, such as trisegmentectomy, are crucial for achieving adequate tumor-free margins in massive tumors.
    • Patient selection and surgical approach are critical for optimizing outcomes in liver cancer surgery.